2Dewachter I, van Dorpe J, Spittaels K, et al. Modeling Alzheimer's disease in transgenie mice: effect of age and of presenilinl on amyloid biochemistry and pathology in APP/London mice[J]. Exp Gerontol, 2000, 35 (6-7): 831.
4Deng HX,Siddique T. Transgenic mouse models and human neurodegenerative disorders[J]. Arch Neurol,2000, 57(12) :1695.
5Song SK,Kim J H,Lin SJ,et al. Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition[J]. Neurobiol Dis,2004,15(3) :640.
6Moran PM, Higgins LS, Cordell B, et al. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein[J]. ProcNatl Acad SciUSA,1995,92(12) :5341.
7Hsiao K, Chapman P, Nilsen S, et al. Correlative memory deficits, Abeta elevation,and amyloid plaques in transgcnic mice[J]. Science,1996,274(5284) :99.
8Jeong YH,Park CH,Yoo J,et al. Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPVT17I-CT100 transgenic mice, an Alzheimer's disease model[J]. FASEB J, 2006,20 (6) : 729.
9Frackowiak J, Miller DL, Potempska A, et al. Secretion and accumulation of Abeta by brain vascular smooth muscle cells from AbetaPP-Swedish transgenic mice [J]. J Neuropathol Exp Neurol, 2003,62 (6) : 685.
10Masliah E, Sisk A, Mallory M, et al. Neurofibrillary pathology in transgenic mice overexpressing VT17F betaamyloid precursor protein[J]. J Neuropathol Exp Neurol,2001,60(7) :357.
二级参考文献15
1Fu AL,Li Q,Dong ZH,et al.Alternative therapy of Alzheimer's disease via supplementation with choline acetyltransferase[J].Neurosci Lett,2004,368(3):258
2Kawahara M,Kato M,Kuroda Y.Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein[J].Brain Res Bull,2001,55(2):211
3Hegde ML,Anitha S,Latha KS.First evidence for helical transitions in supercoiled DNA by amyloid Beta Peptide (1-42) and aluminum:a new insight in understanding Alzheimer's disease[J].J Mol Neurosci,2004,22(1-2):19
4Frantschy SA,Yang F,Calderon L,et al.Rodent model of Alzheimer's disease:rat A beta infusion approaches to amyloid deposits[J].Neurobiol Aging,1996,17(2):311
5Lesne S,Docagne F,Gabriel C.Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice[J].J Biol Chem,2003,278(20):18408
6Urani A,Romieu P,Roman FJ,et al.Enhanced antidepressant efficacy of sigma1 receptor agonists in rats after chronic intracerebroventricular infusion of beta-amyloid-(1-40) protein[J].Eur J Pharmacol,2004,486(2):151
7Giovannelli L,Casamenti F,Scali C.Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis[J].Neuroscience,1995,66(4):781
8Miu AC,Andreescu CE,Vasiu R,et al.A behavioral and histological study of the effects of long-term exposure of adult rats to aluminum[J].Int J Neurosci,2003,113(9):1197
9Kaneko N,Yasui H,Takada J,et al.Orally administrated aluminum-maltolate complex enhances oxidative stress in the organs of mice[J].J Inorg Biochem,2004,98(12):2022
10Ben Ari Y,Tremblely E,Ollergen OP,et al.The role of epileptic activity in hippocampal and remove cerebral lesions induced by bainic[J].Brain Res,1980,(9):79
5Crews L,Masliah E.Molecular mechanisms of neurodegeneration in Alzheimer's disease[J].Hum Mol Genet,2010,19(R1):R12-20.
6Yu L,Edalji R,Harlan JE,et al.Structural characterization of a soluble amyloidβ-peptide oligomer[J].Biochemistry,2009,48(9):1870-1877.
7Haass C,Selkoe DJ.Soluble protein oligomers in neurodegeneration:lessons from the Alzheimer's amyloid beta-peptide[J].Nat Rev Mol Cell Boil,2007,8(2):101-112.
8Ferreira ST,Vieira MN,De Felice FG.Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases[J].IUBMB Life,2007,59(4/5):332-345.
9Allaman I,Gavillet M,Bélanger M,et al.Amyloid-βaggregates cause alterations of astrocytic metabolic phenotype:Impact on neuronal viability[J].J Neurosic,2010,30(9):3326-3338.
10Hardy J,Selkoe DJ.The amyloid hypothesis of Alzheimers's disease:progress and problems on the road to therapeuties[J].Science,2002,297(5580):353-356.
